AXSM vs GILD · rev $409.6M vs P/E 18, rev $7.80B
Axsome Therapeutics Inc (AXSM) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
AXSM currently screens at market cap $11.96B. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the AXSM and GILD stock pages for the full models.
Not investment advice.